EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Lucid Diagnostics's enterprise value is $61.27 Mil.
Lucid Diagnostics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2.43 Mil. Therefore, Lucid Diagnostics's EV-to-Revenue for today is 25.23.
The historical rank and industry rank for Lucid Diagnostics's EV-to-Revenue or its related term are showing as below:
LUCD'
s EV-to-Revenue Range Over the Past 10 Years
Min: 18.09 Med: 72.62 Max: 2014.11
Current: 25.25
During the past 5 years, the highest EV-to-Revenue of Lucid Diagnostics was 2014.11. The lowest was 18.09. And the median was 72.62.
LUCD's EV-to-Revenue is ranked worse than 91.5% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: 3.235
vs LUCD: 25.25
The historical data trend for Lucid Diagnostics's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lucid Diagnostics's EV-to-Revenue
For the Medical Devices subindustry, Lucid Diagnostics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lucid Diagnostics's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lucid Diagnostics's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Lucid Diagnostics's EV-to-Revenue falls into.
Lucid Diagnostics's current Enterprise Value is $61.27 Mil.
Lucid Diagnostics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lucid Diagnostics's share price for today is $0.9101.
Lucid Diagnostics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lucid Diagnostics EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Lucid Diagnostics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Lucid Diagnostics (Lucid Diagnostics) Business Description
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LUCD has been successfully added to your 